Skip to main content
eScholarship
Open Access Publications from the University of California

Efficacy and safety of Atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE):52-week data (April-SLE randomised trial)

  • Author(s): Wofsy, David
  • Isenberg, D
  • Gordon, C
  • Licu, D
  • Copt, S
  • Rossi, CP
  • et al.

Published Web Location

http://europepmc.org/articles/PMC4680140?pdf=render
No data is associated with this publication.
Abstract

Objectives: Despite advances in systemic lupus erythematosus (SLE) treatment, many patients suffer from the disease and side effects. Atacicept is a fusion protein that blocks B-lymphocyte stimulator and a proliferationinducing ligand, which are increased

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item